Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2001
10/11/2001WO2001074896A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001WO2001074835A1 O-glucosylated benzamide sglt2 inhibitors and method
10/11/2001WO2001074834A1 O-aryl glucoside sglt2 inhibitors and method
10/11/2001WO2001074809A1 Acylthiophene derivatives and use thereof as drugs
10/11/2001WO2001074791A1 Diazepane derivatives or salts thereof
10/11/2001WO2001074413A1 Medical devices suitable for gene therapy regimens
10/11/2001WO2001074344A2 Small organic molecule regulators of cell proliferation
10/11/2001WO2001074333A1 D and l etherlipid stereoisomers and liposomes
10/11/2001WO2001066139A8 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell
10/11/2001WO2001025269A3 Human g-protein coupled receptor
10/11/2001WO2001019826A3 Triazolopyrimidine derivatives
10/11/2001WO2000076556A3 High dose radionuclide complexes for bone marrow suppression
10/11/2001US20010029034 Hemostasis system-related disorders treatment
10/11/2001US20010028898 Steam boiling, drying, reboiling
10/11/2001US20010028880 Administering protein c
10/11/2001DE10015814A1 Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung Medicines to stimulate leukopoiesis, for the treatment of tumors and protozoal diseases and process for its preparation
10/11/2001CA2404572A1 Inhibition of thrombosis by treatment with p-selectin antagnosits
10/11/2001CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same
10/11/2001CA2404501A1 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides
10/11/2001CA2404413A1 Small organic molecule regulators of cell proliferation
10/11/2001CA2404376A1 O-glucosylated benzamide sglt2 inhibitors and method
10/11/2001CA2404373A1 O-aryl glucoside sglt2 inhibitors and method
10/11/2001CA2404300A1 Medical devices suitable for gene therapy regimens
10/11/2001CA2404074A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001CA2402864A1 D and l etherlipid stereoisomers and liposomes
10/10/2001EP1142890A1 Aminopyrazole derivatives
10/10/2001EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents
10/10/2001EP1141728A1 Kidney disease detection and treatment
10/10/2001EP1141395A1 Single nucleotide polymorphism in a pyruvate dehydrogenase kinase isoenzyme 2 (pdk2) in humans
10/10/2001EP1141339A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
10/10/2001EP1141334A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
10/10/2001EP1141332A1 Human cyclic nucleotide pdes
10/10/2001EP1141300A1 Nucleic acids and proteins corresponding to mutants of g-csf with granulopoietic activity
10/10/2001EP1141288A2 Lymphocytic membrane proteins
10/10/2001EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy
10/10/2001EP1141266A2 Expression vectors comprising multiple shear stress responsive elements (ssre) and a gene of interest and methods of use thereof
10/10/2001EP1141240A1 Use of cd40 engagement to alter t cell receptor usage
10/10/2001EP1141027A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
10/10/2001EP1141022A1 Serine protease inhibitor
10/10/2001EP1140989A1 Alpha(v) beta(6) integrin inhibitors
10/10/2001EP1140945A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
10/10/2001EP1140943A2 Substituted pyrroloindoles
10/10/2001EP1140941A1 Nitrogen containing heterobicycles as factor xa inhibitors
10/10/2001EP1140918A1 Thrombin inhibitors
10/10/2001EP1140905A1 Heteroaromatic amides as inhibitor of factor xa
10/10/2001EP1140903A1 Aromatic amides
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140881A1 Antithrombotic amides
10/10/2001EP1140871A1 Thrombin or factor xa inhibitors
10/10/2001EP1140863A1 1,4-diazacycloheptane derivatives useful in the treatment of neurological disorders
10/10/2001EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140839A1 Heterocyclic amides as inhibitors of factor xa
10/10/2001EP1140836A1 Amide compounds
10/10/2001EP1140825A1 Melatonin derivatives and medicine containing same
10/10/2001EP1140820A1 New amidino derivatives and their use as thrombin inhibitors
10/10/2001EP1140802A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines
10/10/2001EP1140783A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp
10/10/2001EP1140243A1 Stent grafts with bioactive coatings
10/10/2001EP1140176A1 Transcutaneous photodynamic treatment of targeted cells
10/10/2001EP1140173A2 Vascular endothelial cell growth factor antagonists and uses thereof
10/10/2001EP1140171A1 Methods and products for regulating lectin complement pathway associated complement activation
10/10/2001EP1140149A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
10/10/2001EP1140120A2 Human brainiac-5
10/10/2001EP1140098A2 Tricyclic nitrogen heterocycles as pde iv inhibitors
10/10/2001EP1140091A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal consitions
10/10/2001EP1140083A1 Novel compounds
10/10/2001EP1140065A1 Use of gamma-tocopherol and its oxidative metabolite llu-alpha in the treatment of disease
10/10/2001EP1140038A1 Transdermal drug delivery system
10/10/2001EP1140035A1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same
10/10/2001EP1140026A1 Biodegradble polymer encapsulated serotonin receptor antagonist and method for preparing the same
10/10/2001EP1140021A1 Improved formulation for topical non-invasive application in vivo
10/10/2001EP1140020A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
10/10/2001EP1140019A1 Aerosol formulations for buccal and pulmonary application
10/10/2001EP1139784A1 Food-induced antisecretory proteins in egg yolk
10/10/2001EP1093378A4 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
10/10/2001EP1083172A4 N-substituted derivatives of 5-oxyiminobarbituric acid
10/10/2001EP0830372B1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability
10/10/2001EP0668909B1 Transgenic, cross-linked hemoglobin
10/10/2001CN1317015A Human anti-factor IX/IXa antibodies
10/10/2001CN1317005A Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
10/10/2001CN1316265A Medicine for treating primary thrombocytopenia purpura
10/10/2001CN1316255A Styptic powder
10/10/2001CN1316243A Application of tea polyphenol and its oxide in treating anemia
10/10/2001CN1072482C Low-molecular heparin liposome spray preparation and its preparation technology
10/09/2001US6300342 Antithrombotic phenylalkyl derivatives
10/09/2001US6300330 Blood coagulation factor x inhibitors as anticoagulants
10/09/2001US6300314 Admnistering heterocyclic peptides to stimulate hematopoiesis of cells
10/09/2001US6300129 Transgenic non-human animals for producing heterologous antibodies
10/09/2001CA2016501C Substituted pyrrole compounds and their applications in pharmacy
10/09/2001CA1341301C Preparation of functional human urokinase proteins
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains
10/04/2001WO2001073002A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001WO2001072960A2 Il-8 receptor antagonists
10/04/2001WO2001072848A1 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
10/04/2001WO2001072843A2 Regulation of human c-myb-related genes
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072823A1 Crystal structure of the (aml1 runt domain) / (cbfbeta) heterodimer and the ternary complex with dna
10/04/2001WO2001072777A2 Human transcription factors
1 ... 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 ... 671